GB0902845D0 - Antidiabetic azabicyclo (3.1.0) hexan compounds - Google Patents

Antidiabetic azabicyclo (3.1.0) hexan compounds

Info

Publication number
GB0902845D0
GB0902845D0 GBGB0902845.7A GB0902845A GB0902845D0 GB 0902845 D0 GB0902845 D0 GB 0902845D0 GB 0902845 A GB0902845 A GB 0902845A GB 0902845 D0 GB0902845 D0 GB 0902845D0
Authority
GB
United Kingdom
Prior art keywords
hexan
antidiabetic
azabicyclo
compounds
hexan compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0902845.7A
Other versions
GB2454615A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of GB0902845D0 publication Critical patent/GB0902845D0/en
Publication of GB2454615A publication Critical patent/GB2454615A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0902845A 2006-07-21 2007-07-20 Antidiabetic azabicyclo (3.1.0) hexan compounds Withdrawn GB2454615A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN730KO2006 2006-07-21
PCT/IN2007/000298 WO2008010238A2 (en) 2006-07-21 2007-07-20 Antidiabetic azabicyclo [3. 1. 0] hexan compounds

Publications (2)

Publication Number Publication Date
GB0902845D0 true GB0902845D0 (en) 2009-04-08
GB2454615A GB2454615A (en) 2009-05-13

Family

ID=38812084

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0902845A Withdrawn GB2454615A (en) 2006-07-21 2007-07-20 Antidiabetic azabicyclo (3.1.0) hexan compounds

Country Status (3)

Country Link
AU (1) AU2007274598A1 (en)
GB (1) GB2454615A (en)
WO (1) WO2008010238A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
FR2932479A1 (en) * 2008-06-13 2009-12-18 Servier Lab NOVEL AZABICYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
DE102010015123A1 (en) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh New benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
ES2861268T3 (en) 2011-09-20 2021-10-06 Basf Se Low molecular weight modulators of the TRPM8 cold menthol receptor and their use
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility
MX2021014441A (en) 2019-05-31 2022-01-06 Ikena Oncology Inc Tead inhibitors and uses thereof.
CA3142351A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CN110237045A (en) * 2019-07-11 2019-09-17 广西大学 A kind of capsule

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (en) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
AU2003214520A1 (en) * 2003-04-09 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists

Also Published As

Publication number Publication date
WO2008010238A3 (en) 2008-04-17
GB2454615A (en) 2009-05-13
AU2007274598A1 (en) 2008-01-24
WO2008010238A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
GB0902845D0 (en) Antidiabetic azabicyclo (3.1.0) hexan compounds
HUS2000019I1 (en) Biocidal boronophthalide compounds
AP2281A (en) Novel compounds.
EP2079467A4 (en) Antidiabetic bicyclic compounds
GB0510142D0 (en) Novel compounds A1
GB0503962D0 (en) Compounds
EP2136810A4 (en) Novel 1,8-naphthyridine compounds
IL225694A0 (en) 5, 6 - dihydro - 1h - pyridin - 2 - one compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0502299D0 (en) Compounds
AP2337A (en) Motilide compounds.
GB0503961D0 (en) Compounds
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
EP1867650A4 (en) Hydroxymethylboron compounds
GB0504640D0 (en) Inks
GB0501984D0 (en) Compounds
EP1940415A4 (en) 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
GB0503145D0 (en) Compounds
PL381338A1 (en) E .38
PL381423A1 (en) S .98
GB0523048D0 (en) Inorganic & carbon fibres
ZA200508047B (en) Welder.
GB0702705D0 (en) IP.Access 1
GB0702708D0 (en) IP.Access 2

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)